Dikhyaa Mohanty 
The World Health Organization has issued a warning over four tainted medications produced by an Indian pharmaceutical business that may be responsible for 66 child fatalities in The Gambia and severe renal damage.
Official publications cite Tedros Adhanom Ghebreyesus, director-general of the WHO, as saying “The four medications are syrups for treating colds and coughs made in India by Maiden Pharmaceuticals Limited. He said that the loss of young lives as a result of the goods is “beyond heartbreaking for their families” and that the WHO is conducting additional inquiry with the manufacturer and regulatory authorities in India “.
Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup are the four products. The maker of these goods is Maiden Pharmaceuticals Limited, located in Haryana, India, and according to WHO, the claimed manufacturer has not yet given assurances on the security and caliber of these goods.
The WHO director stated that although the tainted items have only been found in The Gambia so far, they may have been exported to other nations. To save people from suffering additional harm, the WHO has advised all nations to identify and halt the distribution of these items. Four subpar items were found in The Gambia and reported to WHO in September 2022, according to the WHO Medical Product Alert.
According to the WHO, inferior medical items are those that fall short of their requirements or quality criteria. Laboratory examination of samples from each of the four items reveals impurities such as diethylene glycol and ethylene glycol at prohibited concentrations.
